viewGrow Group Plc

Grow Pharma to produce medicinal cannabis oil in UK to ease Brexit disruption

Grow Pharma’s partner, IPS Pharma, will produce the cannabis oils at its certified production facility in Surrey.

Grow Group Plc - Grow Pharma starts producing medical cannabis oil in UK to ease Brexit disruption

Grow Pharma said it has started trials to extract cannabis-based medical products in the UK, making it only the second company to have done so after GW Pharmaceuticals (NASDAQ:GWPH). 

Privately-owned distributor Grow, part of Grow Group Plc, said it is attempting to replicate and distribute cannabis-based medicinal products (CBMPs) for patients experiencing Brexit disruption to supplies.

Grow Pharma said it is already legally importing GMP produced Bedrocan flowers into the UK for distribution to medicinal cannabis patients.

Bedrocan strains are used to produce the cannabis oil that around 40 families were collecting from a Dutch pharmacy.

“A post-Brexit, sustainable and UK based solution for this problem is needed and we are ready to step up to help,” said Pierre van Weperen, Grow Pharma’s chief executive.

He also mentioned that when prescriptions come in, initial samples will be made available free of charge and, in future, prices will be significantly less than parents are used to paying.

Grow’s partner, IPS Pharma, will produce the cannabis oils at its certified production facility in Surrey.

“ This is an opportunity to establish a UK-based solution that can produce CBMPs to the highest possible standards,” said van Weperen.

“We will be using the exact same starting material these patients are used to. From a scientific standpoint there is no reason why the end result would differ significantly beyond any fluctuations that may have arisen already within the current production process,” explained Ashok Patel, a pharmacist at IPS Pharma.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...


Grow Group Plc 'excited about the growing community we're building' with aim...

Grow Group Plc Community & Investor Relations Lead Hannah Nomme joins Proactive London's Katie Pilbeam to talk about the launch of the UK’s largest-ever cannabis crowdfunding campaign - with an aim to raise £3.2mln to help scale up operations. The firm is aiming to seize upon the UK’s...

on 9/8/21

2 min read